China Chinese Healthcare
The Chinese medical aesthetics industry is undergoing a significant transformation as it reaches a turning point with the saturation of traffic dividends and the explicit cost of compliance. Today, global leader in the medical aesthetics field, Elgin Aesthetics, in collaboration with Deloitte China, unveiled the ‘Insights Report on China’s Medical Aesthetics Industry 2026.’ The report, based on in-depth surveys of 2,000 beauty seekers and 200 operators/doctors, highlights that the industry has entered a period of deep adjustment towards “quality upgrading and coexisting changes.” The industry is shifting its growth logic from “traffic competition” to “capability competition,” with a coexistence of…
News Timeline:
Track the development of this news story across the Internet.